Diapharm's Ralf Sibbing will be explaining the pharmaceutical market in Germany during the "Main Forum: Policy and Market" during the CPhI China in Shanghai. The general manager of Diapharm will discuss opportunities and challenges of entering the EU regulated market, with a particular focus on Germany. The CPhI China conference and trade fair draws over 30.000 visitors and is one of the world's biggest business events for manufacturers and exporters of pharmaceutical products.
The "Main Forum: Policy and Market" takes place on 26 June in Hall E1 M16 Meeting Room:
- 10:00 - 10:20 Opening Speech (LIU Zhanglin, Vice President CCCMHPIE)
- 10:20 - 11:00 Increasing China’s Competitivenss in Pharmaceutical Sector (Tan Shengcai, Vice Secretary-General CCCMHPIE)
- 11:00 - 11:30 Analysis of API Export (Cao Gang, Director CCCMHPIE)
- 11:30 - 12:00 Analysis of Export Market of Dietary Supplements (Zhang Zhongpeng, Vice Director CCCMHPIE)
- 13:30 - 14:00 Opportunities in China-UK Healthcare Cooperation (Clive Allcorn, UK Trade & Investment)
- 14:00 - 14:30 Outlook on Deeping China-India Pharmaceutical Cooperation (Namgya C. Khampa, Commercial Counselor of India to China)
- 14:30 - 15:10 Current Status and Prospect of China-Denmark Healthcare Cooperation (Victor Malecki, Counselor of Denmark to China)
- 15:10 - 15:50 Entering EU regulated market: German Pharmaceutical Market - Opportunities and Challenges (Ralf Sibbing, General Manager Diapharm GmbH & Co. KG)
- 15:50 - 16:20 Current Status and Analysis on Drug Registration Procedures in US Market (n.n.)
Further Information
